期刊文献+

nm23,整合素α_5β_1和VEGF在乳腺癌中的表达及其意义 被引量:1

Significance of the expression of nm23,integrin α_5β_1 and VEGF in breast cancer
下载PDF
导出
摘要 目的 检测nm 2 3 ,整合素α5β1 和VEGF在乳腺癌中的表达及其相互关系 ,以探讨其对乳腺癌发展的影响。方法 采用免疫组化法检测 5 1例乳腺癌标本中nm 2 3 ,α5β1 和VEGF的表达 ,分析其相关性。结果 乳腺癌组织中nm 2 3的低表达与淋巴结转移密切相关 ,α5β1 的低表达和VEGF的高表达与淋巴结转移和组织学低分化密切相关。nm 2 3和α5β1 的表达呈正相关 (P <0 .0 5 )而α5β1 与VEGF的表达呈负相关 (P <0 .0 5 )。结论 乳腺癌组织中nm 2 3和α5β1 的低表达及VEGF的高表达可作为早期识别具有高浸润和转移潜能的乳腺癌及判断其预后的参考指标。 Objective To investigate the expression of nm23,integrin α 5β 1 and VEGF in breast cancer(BC),and the effect of the expression on the development of BC. Methods The expression of nm23, integrin α 5β 1 and VEGF in 51 patients with breast cancer were examined by immunohistochemistry,and their correlatios were ananlyzed. Results The low expression of nm23 in BC tissue was associated with lymph nodes metastasis. The low expression of integrin α 5β 1 and the high expression of VEGF in BC tissues were associated with the lymph nodes metastasis and low differentiation of the tumor.The expression of nm23 and integrin α 5β 1 in breast cancer tissues had positive correlation(P<0.05),and the expression of integrin α 5β 1 and VEGF had negative correlation(P<0.05). Conclusions The low expression of nm23 and integrin α 5β 1, and the high exprssion of VEGF are useful maker that can be used to identify high aggressive, metastatic potential in patients with BC at early stage,and can predict the prognosis of BC.
作者 吴诚义 陈晋
出处 《中国普通外科杂志》 CAS CSCD 2003年第10期739-741,共3页 China Journal of General Surgery
关键词 乳腺肿瘤/病理学 淋巴转移 NM23 整合素Α5Β1 血管生长因子 BREAST NEOPLASMS/pathol LYMPH METASTASIS nm23 INTEGRINα 5β 1 VEGF
  • 相关文献

参考文献6

  • 1袁建达,邵志敏,韩企,夏沈镇.整合素亚型α5β1基因抑制乳腺癌增殖和转移的作用[J].实用癌症杂志,1999,14(1):1-5. 被引量:10
  • 2陈晋,吴诚义.nm23基因及其在乳腺癌中的研究现状[J].医学综述,2002,8(8):437-438. 被引量:2
  • 3Varner JA, Cheresh DA. Integrin and cancer [ J ]. Curr Opin Cell Bio1,1996,8(5) :724-730.
  • 4Varener JA. The role of vascular cell inteprins alpha V beta 3 and alpha V beta 5 in angiogennesis [ J]. EXS, 1997, 79(3) :361 -390.
  • 5Hebbar M, Peyrat JP. Significance of soluble endothelial molecule E- selection in patients with breast cancer [ J ] . Int J Biol Makers ,2000,15 ( 1 ) : 15 - 21.
  • 6Luscinskas FW, Lauler J. Integrins as dynamic regulator of vascular function[J]. FASEB J,1994,8(12) :929 -938.

二级参考文献5

共引文献10

同被引文献9

  • 1吴唯,吕新生,唐中华,张翼,李小荣,陈道瑾.乳腺癌组织中VEGF mRNA的表达及其临床意义[J].中国普通外科杂志,2004,13(11):813-816. 被引量:5
  • 2唐金海,赵建华,徐甫保,秦建伟,龚建平.肿瘤切除和术后复发对乳腺癌患者血管生成平衡的影响[J].中国普通外科杂志,2005,14(9):672-675. 被引量:1
  • 3Yu J,Bian D,Mahanivong C,et al.p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression[J].J Biol Chem,2004,279(48):50446 -50454.
  • 4Dano K,Andreason PA,Grondahl-Hansen K,et al.Plasminogen activators,tissue degradation and cancer[J].Adv Cancer Res,1985,44(2):139 -266.
  • 5Neufeld G,Tessler S,Weindel K,et al.vascular permeability factor and its receptors[J].Prog Growth Factor Res,1994,5(1):89 -97.
  • 6Toi M,Hoshina S,Takayanagi T,et al.Association of vascular endothelial growth factor expression with tumor angiogensis and with early relapse in breast cancer[J].Jpn J Cancer Res,1994,85(10):1045-1049.
  • 7Manders P,Tjan-Heijnen VC,Span PN,et al.The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-Ⅰ) independently predicts response to first-line endocrine therapy in advanced breast cancer[J].Thromb Haemost.2004,91 (3):514 -521.
  • 8Duffy MJ.The urokinase plasminogen activator system:role in malignancy[J].Curr Pharm Des,2004,10 (1):39-49.
  • 9肖继平,於席芳,徐翠琼,张莉,何赋容,王梅林,张广德,夏文华.腋淋巴结阴性乳腺癌uPA表达的临床意义[J].中华肿瘤杂志,2004,26(3):188-188. 被引量:19

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部